NorthWest Biotherapeutics Inc (NWBO)

[manibiotech]

"What is likely happening here is that NHS has looked at all of DCVax-L's data and concluded that they need to get this treatment to its citizenry NOW. So, the NHS is using IFR funding to jump-start DCVax-L accessibility. It's as if NHS said to NICE, " DCVax-L is a godsend. We need to make this available now"
That's why MHRA hasn't granted MAA for almost year and a half now . And NHS couldn't talk to MHRA and say the same . They only have phone number of NICE?